Antimicrobial activity of oleanolic acid from Salvia officinalis and related compounds on vancomycin-resistant enterococci (VRIE)

被引：159
|
作者：
Horiuchi, Kumiko
Shiota, Sumiko
Hatano, Tsutomu
Yoshida, Takashi
Kuroda, Teruo
Tsuchiya, Tomofusa [1 ]
机构：
[1] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Mol Microbiol, Okayama 7008530, Japan
[2] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pharmacognosy, Okayama 7008530, Japan
[3] Shujitsu Univ, Sch Pharm, Dept Biol Pharm, Lab Pathogen Microbiol, Okayama 7038516, Japan
来源：
BIOLOGICAL & PHARMACEUTICAL BULLETIN | 2007年 / 30卷 / 06期
关键词：
oleanolic acid; ursolic acid; vancomycin-resistant enterococci (VRE); bactericidal activity; Sage;
D O I：
10.1248/bpb.30.1147
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
An extract from Salvia officinalis (Sage) leaves showed antimicrobial activity against vancomycin-resistant enterococci (VRE). We isolated the effective compound and identified it as oleanolic acid, a triterpenoid. We also tested antimicrobial activity of similar triterpenoids, ursolic acid, uvaol, betulinic acid and betulin. We found that ursolic acid also showed antimicrobial activity against VRE. The minimum inhibitory concentrations (MICs) of oleanolic acid and ursolic acid were 8 and 4 mu g/ml, respectively. These two compounds also showed antimicrobial activity against Streptococcus pneumoniae and methicillin-resistant Staphylococcus aureus (MRSA). These compounds showed bactericidal activity against VRE at least for 48 h when added at concentrations that were two-times higher than their MICs.
引用
收藏
页码：1147 / 1149
页数：3
相关论文
共 50 条
  • [21] Vancomycin-resistant enterococci: Risk related to the use of intravenous vancomycin in a university hospital
    Fuller, RE
    Harrell, LJ
    Meredith, FT
    Sexton, DJ
    Colvin, LG
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1998, 19 (11): : 821 - 823
  • [22] Nosocomial transmission of vancomycin-resistant enterococci from surfaces
    Ray, AJ
    Hoyen, CK
    Taub, TF
    Eckstein, EC
    Donskey, CJ
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (11): : 1400 - 1401
  • [23] Vancomycin-resistant enterococci from animal sources in Korea
    Jung, Woo Kyung
    Lim, Ji Youn
    Kwon, Nam Hoon
    Kim, Jun Man
    Hong, Soon Keun
    Koo, Hye Cheong
    Kim, So Hyun
    Park, Yong Ho
    INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY, 2007, 113 (01) : 102 - 107
  • [24] Vancomycin-resistant enterococci isolated from animals and food
    Robredo, B
    Singh, KV
    Baquero, F
    Murray, BE
    Torres, C
    INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY, 2000, 54 (03) : 197 - 204
  • [25] In Vitro Activity of Linezolid and Dalbavancin Against Vancomycin-Resistant Enterococci
    Aktas, Gulseren
    Bozdogan, Bulent
    Derbentli, Sengul
    MIKROBIYOLOJI BULTENI, 2012, 46 (03): : 359 - 365
  • [26] What is the potential danger from vancomycin-resistant enterococci?
    Witte, W
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1997, 122 (38) : 1161 - 1163
  • [27] In-vitro activity of fosfomycin against vancomycin-resistant enterococci
    Allerberger, F
    Klare, I
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (02) : 211 - 217
  • [28] Isolation of vancomycin-resistant enterococci from supermarket poultry
    Kirk, M
    Hill, RLR
    Casewelll, MW
    Beighton, D
    STREPTOCOCCI AND THE HOST, 1997, 418 : 289 - 291
  • [29] Two cases of vancomycin-resistant enterococci from Singapore
    Chiew, YF
    Ling, ML
    JOURNAL OF INFECTION, 1998, 36 (01) : 133 - 134
  • [30] In vitro activity of salicylamide derivatives against vancomycin-resistant enterococci
    Pospisilova, Sarka
    Michnova, Hana
    Kauerova, Tereza
    Pauk, Karel
    Kollar, Peter
    Vinsova, Jarmila
    Imramovsky, Ales
    Cizek, Alois
    Jampilek, Josef
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (12) : 2184 - 2188
12345